CN Patent

CN105764905B — 新的八氢-环丁二烯并[1，2-c；3，4-c’]二吡咯-2基

Assigned to F Hoffmann La Roche AG · Expires 2019-06-07 · 7y expired

What this patent protects

本发明提供新的化合物，其具有通式(I)，其中R 1 、Y和R 2 如本文中所述，包含所述化合物的组合物和使用所述化合物的方法。

USPTO Abstract

本发明提供新的化合物，其具有通式(I)，其中R 1 、Y和R 2 如本文中所述，包含所述化合物的组合物和使用所述化合物的方法。

Drugs covered by this patent

Patent Metadata

Patent number
CN105764905B
Jurisdiction
CN
Classification
—
Expires
2019-06-07
Drug substance claim
No
Drug product claim
No
Assignee
F Hoffmann La Roche AG
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.